Response to Letter to the Editor From Rosenfield et al: "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome"
- PMID: 38809769
- DOI: 10.1210/clinem/dgae370
Response to Letter to the Editor From Rosenfield et al: "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome"
Keywords: guidelines; hirsutism; polycystic ovary syndrome.
Comment in
-
Letter to the Editor From Rosenfield, et al: "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome".J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1962-e1963. doi: 10.1210/clinem/dgae368. J Clin Endocrinol Metab. 2024. PMID: 38809759 No abstract available.
Comment on
-
Letter to the Editor From Rosenfield, et al: "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome".J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1962-e1963. doi: 10.1210/clinem/dgae368. J Clin Endocrinol Metab. 2024. PMID: 38809759 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
